A group of UCL Mental Health Masters students summarise an RCT on the clinical and cost-effectiveness of the MARQUE intervention (Managing Agitation and Raising Quality of Life) for agitation in people with dementia in care homes.
[read the full story...]
John Baker explores a systematic review of compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness.
[read the full story...]
Liz Collier and Solomon Towuru summarise the recently updated Cochrane systematic review on reminiscence therapy for dementia, which includes evidence showing that reminiscence therapy may improve quality of life, cognition, communication and possibly mood in people with dementia in some circumstances, although all the benefits were small.
[read the full story...]
91 diabetic patients were randomised to non-surgical scaling and root planing and amoxicillin or control. While periodontal status significantly improved at 3 months there was no no significant effects on
glycaemic control.
Clarissa Giebel unfolds and reviews a new roadmap to advance dementia research in prevention, diagnosis, intervention and care by 2025.
[read the full story...]
Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.
[read the full story...]
Inês Pote summarises a recent meta-analysis of randomised placebo-controlled trials of cognitive behavioural therapy for anxiety and related disorders.
[read the full story...]
Hilary Shepherd reports on a recent paper from the WHELD trial on the impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes.
[read the full story...]
Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia.
[read the full story...]
Ian Cummins considers the findings of a recent 48-month follow-up study of social outcomes for patients with psychosis, which concludes that community treatment orders did not offer any long term benefits.
[read the full story...]
